FLASH SPRING SALE: 50% Off Premium Subscription >> FLASH SPRING SALE: 50% Off Premium >>
NYSE:PFNX
Delisted

Pfenex Inc Stock News

New York Stock Exchange
Open Broker Account
$12.75
+0 (+0%)
At Close: Dec 08, 2021
Forecast Insider Trading Signals Historical Prices Predictions News Profile

Pfenex Reports Licensee, Serum Institute Of India Private, Completed Pivotal Phase 3 Study For Pneumoisl; Primary, Secondary Objectives Were Met

 12:00am, Wednesday, 06'th Mar 2019

81 Biggest Movers From Friday

 12:00am, Monday, 04'th Mar 2019

Pfenex And Alvogen Earlier Announced Agreement o Expand Development And Commercialization Collaboration For PF708, A Therapeutic Equivalent Candidate To Forteo/Forsteo, To The EU, MENA And ROW

 12:00am, Thursday, 28'th Feb 2019

Pfenex Announces FDA Acceptance Of NDA For PF708

 12:00am, Tuesday, 19'th Feb 2019

46 Biggest Movers From Yesterday

 12:00am, Tuesday, 11'th Dec 2018

Pfenex Submits New Drug Application To U.S. FDA Seeking Approval Of PF708 For The Treatment Of Osteoporosis

 12:00am, Monday, 10'th Dec 2018

48 Biggest Movers From Yesterday

 12:00am, Friday, 30'th Nov 2018

41 Biggest Movers From Yesterday

 12:00am, Tuesday, 27'th Nov 2018

Pfenex's (PFNX) CEO Eef Schimmelpennink on Q3 2018 Results - Earnings Call Transcript

 12:00am, Sunday, 11'th Nov 2018

Pfenex Q3 EPS $(0.34), Inline, Sales $3.57M Miss $4.4M Estimate

 12:00am, Wednesday, 07'th Nov 2018

The Week Ahead In Biotech: Earnings, Conferences, PDUFA Dates, Clinical Trial Results And IPOs

 12:00am, Sunday, 04'th Nov 2018
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE